PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Hofer, T.P. ; Nieto, A.* ; Kaesmann, L.* ; Taugner, J.* ; Pelikan, C. ; Katanov, D.* ; Eze, C.* ; Guggenberger, J.* ; Belka, C.* ; Nößner, E. ; Manapov, F.*

Absence of CD4(+) and CD8(+) T cell expansion after primary multimodal treatment predicts early progression in inoperable stage III NSCLC.

J. Clin. Oncol. 40:e20590 (2022)
Publ. Version/Full Text
Closed
Open Access Green as soon as Postprint is submitted to ZB.
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Meeting abstract
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 0732-183X
e-ISSN 1527-7755
Journal Journal of Clinical Oncology - JCO
Quellenangaben Volume: 40, Issue: 16, Pages: , Article Number: e20590 Supplement: ,
Publisher American Society of Clinical Oncology
Reviewing status Peer reviewed
Institute(s) Institute of Virology (VIRO)
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Immune Response and Infection
PSP Element(s) G-502710-001
WOS ID WOS:000863680304225
Erfassungsdatum 2023-01-10
[➜Report correction]